Clinical Trial Update: 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the minimum effective dose of flibanserin (25 mg BID, 50 mg BID, 50 mg at bedtime) versus placebo over six months in younger North Amer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Flibanserin (Flibanserin)

Snippet

Sponsor: Sprout Pharmaceuticals, Inc | Conditions: Sexual Dysfunctions, Psychological | Phase 3 | Status: COMPLETED | Results posted: 2016-06-27